Xin Zhang

Prof. Dr. Xin Zhang

Institute of Process Engineering, Chinese Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in ACS Nano
Verified
Journal Article
Closed access
HPHuan Peng
Huan Peng
YLYan Li
Yan Li
WJWeihong Ji
Weihong Ji
RZRuichen Zhao
Ruichen Zhao
ZLZhiguo Lu
Zhiguo Lu
Xin ZhangXin Zhang
Xin Zhang

17 July 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
HPHuan Peng
Huan Peng
WJWeihong Ji
Weihong Ji
RZRuichen Zhao
Ruichen Zhao
JYJun Yang
Jun Yang
ZLZhiguo Lu
Zhiguo Lu
Xin ZhangXin Zhang
Xin Zhang
In recent years, due to the limitations of the nature of therapeutic agents, many synthetic nano-delivery systems have emerged to enhance the efficacy of drugs. Extracellular vesicles are currently a class of natural nano-scale drug carriers released by cells. As a tiny vesicle with a lipid bilayer membrane that can be secreted by most cells in the body, exosomes carry and transmit important signal molecules, Therefore, they have been a research hotspot in biomedicine and biomaterials due to their size advantages and huge potential in drug therapy. Many people are optimistic about the clinical application prospects of exosomes and are actively exploring the broad functions of exosomes and developing exosome therapeutic agents to make positive contributions to human health. In this review, we provide basic knowledge and focus on summarizing the advantages of exosomes as drug carriers, methods of loading drugs, targeting strategies, in vivo and in vitro tracing methods, and some of the latest developments in exosomes as drug carriers. In particular, the review provides an outlook for this field.

25 March 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
CQChenmeng Qiao
Chenmeng Qiao
JYJun Yang
Jun Yang
QSQi Shen
Qi Shen
RLRuiyuan Liu
Ruiyuan Liu
YLYanhui Li
Yanhui Li
Xin ZhangXin Zhang
Xin Zhang

11 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LLLinying Liu
Linying Liu
YLYan Li
Yan Li
HPHuan Peng
Huan Peng
RLRuiyuan Liu
Ruiyuan Liu
WJWeihong Ji
Weihong Ji
Xin ZhangXin Zhang
Xin Zhang
The most critical problem in the treatment of neurodegenerative diseases is brain neuronal protection, which can be overcome by clearing pathological substances and regulating the immune environment. In the above treatment strategies, the traditional poor drug delivery problem is inevitable. Here, we show an engineering core-shell hybrid system named rabies virus glycoprotein (RVG) peptide–modified exosome (EXO) curcumin/phenylboronic acid-poly(2-(dimethylamino)ethyl acrylate) nanoparticle/small interfering RNA targeting SNCA (REXO-C/ANP/S). It is a nanoscavenger for clearing α-synuclein aggregates and reducing their cytotoxicity in Parkinson’s disease neurons. The motor behavior of Parkinson’s disease mice is substantially improved after REXO-C/ANP/S treatment. In particular, we demonstrate that REXO-C/ANP/S is also a nanoscavenger for clearing immune activation due to its natural immature dendritic cell EXO coating. Our findings show that REXO-C/ANP/S may serve as a platform for neurodegenerative diseases treatment.

13 August 2015 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
BHBingbing Hu
Bingbing Hu
FDFengying Dai
Fengying Dai
ZFZhanming Fan
Zhanming Fan
GMGuanghui Ma
Guanghui Ma
QTQunwei Tang
Qunwei Tang
Xin ZhangXin Zhang
Xin Zhang

6 May 2015 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
HDHeng Deng
Heng Deng
FDFengying Dai
Fengying Dai
GMGuanghui Ma
Guanghui Ma
Xin ZhangXin Zhang
Xin Zhang